SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-039620
Filing Date
2019-08-13
Accepted
2019-08-13 17:11:43
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv527046_10q.htm 10-Q 497554
2 EXHIBIT 31.1 tv527046_ex31-1.htm EX-31.1 10410
3 EXHIBIT 31.2 tv527046_ex31-2.htm EX-31.2 10455
4 EXHIBIT 32.1 tv527046_ex32-1.htm EX-32.1 4093
5 EXHIBIT 32.2 tv527046_ex32-2.htm EX-32.2 4517
  Complete submission text file 0001144204-19-039620.txt   2824102

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycc-20190630.xml EX-101.INS 446457
7 XBRL TAXONOMY EXTENSION SCHEMA cycc-20190630.xsd EX-101.SCH 30164
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycc-20190630_cal.xml EX-101.CAL 35265
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20190630_def.xml EX-101.DEF 122799
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20190630_lab.xml EX-101.LAB 319123
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20190630_pre.xml EX-101.PRE 210000
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 191021689
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1